Tony has 30 years of experience in the pharmaceutical industry in various global management and medicines development roles for companies in the United States and Europe, He has been passionate about patient involvement in the development and life cycle of medicines for many years and he is one of the founders of ‘Patient Focused Medicines Development’ (PFMD). Tony most recently served as EVP and CMO for Integral Health in Boston, MA. Prior to that he was the Chief of Medical for Amgen in Europe, which included all therapeutic areas as well as all medical departments in Europe.

Prior to Amgen, Tony was a Senior Vice President for GSK at the corporate headquarters in London; his responsibilities over time included European Medical Affairs, Head of the Rare Disease Business Unit and senior associate of the Chief Medical Officer. Preceding GSK Tony was a member of the Executive Management Board of Merck Serono (Geneva, Switzerland); his area of responsibility was Global Drug Development and all related functions. He also had a long executive career in R&D with Aventis and its predecessor companies both in the US and Europe. Dr. Hoos is a licensed physician; he studied and trained in Germany and the US. He also holds a Masters of Business Administration from the University of Toronto, Canada.